201 related articles for article (PubMed ID: 34094682)
1. Addition of bromelain and acetylcysteine to gemcitabine potentiates tumor inhibition
Mekkawy AH; Pillai K; Badar S; Akhter J; Ke K; Valle SJ; Morris DL
Am J Cancer Res; 2021; 11(5):2252-2263. PubMed ID: 34094682
[TBL] [Abstract][Full Text] [Related]
2. Bromelain and acetylcysteine (BromAc
Mekkawy AH; Pillai K; Suh H; Badar S; Akhter J; Képénékian V; Ke K; Valle SJ; Morris DL
Am J Transl Res; 2021; 13(12):13524-13539. PubMed ID: 35035694
[TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal BromAc
Mekkawy AH; Breakeit M; Pillai K; Badar S; Akhter J; Valle SJ; Morris DL
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444430
[TBL] [Abstract][Full Text] [Related]
4. A novel treatment of bromelain and acetylcysteine (BromAc) in patients with peritoneal mucinous tumours: A phase I first in man study.
Valle SJ; Akhter J; Mekkawy AH; Lodh S; Pillai K; Badar S; Glenn D; Power M; Liauw W; Morris DL
Eur J Surg Oncol; 2021 Jan; 47(1):115-122. PubMed ID: 31679953
[TBL] [Abstract][Full Text] [Related]
5. Effect of Nebulized BromAc on Rheology of Artificial Sputum: Relevance to Muco-Obstructive Respiratory Diseases.
Pillai K; Mekkawy AH; Akhter J; Morris DL
Adv Respir Med; 2023 Apr; 91(2):146-163. PubMed ID: 37102780
[TBL] [Abstract][Full Text] [Related]
6. Ex-vivo mucolytic and anti-inflammatory activity of BromAc in tracheal aspirates from COVID-19.
Coelho Dos Reis JGA; Ferreira GM; Lourenço AA; Ribeiro ÁL; da Mata CPDSM; de Melo Oliveira P; Marques DPA; Ferreira LL; Clarindo FA; da Silva MF; Filho HPP; Oliveira NRR; Sodré MMD; Gadelha SR; Albuquerque GR; Maciel BM; Mariano APM; Silva MM; Fontana R; Marin LJ; Carlos RSA; Lopes ATS; Ferreira FB; Dos Santos UR; Santana ÍTS; Fehlberg HF; Rezende RP; Dias JCT; Gross E; Goulart GAC; Santiago MG; de Lemos APML; da Conceição AO; Romano CC; de Carvalho LD; Martins Filho OA; Quadros CA; Morris DL; Valle SJ
Biomed Pharmacother; 2022 Apr; 148():112753. PubMed ID: 35272139
[TBL] [Abstract][Full Text] [Related]
7. Bromelain and acetylcysteine (BromAc
Wen HK; Valle SJ; Morris DL
Am J Cancer Res; 2023; 13(4):1522-1532. PubMed ID: 37168359
[TBL] [Abstract][Full Text] [Related]
8. A novel method for potentiation of chemotherapy in soft tissue sarcomas with BromAc.
Dong L; Ke K; Badar S; Mekkawy AH; Akhter J; Pillai K; Carter CJ; Morris DL
Am J Transl Res; 2022; 14(5):2894-2909. PubMed ID: 35702130
[TBL] [Abstract][Full Text] [Related]
9. The effect of intraperitoneal administration of BromAc on blood parameters: phase 1 study.
Ke K; Pillai K; Mekkawy AH; Akhter J; Badar S; Valle SJ; Morris DL
Discov Oncol; 2021 Aug; 12(1):25. PubMed ID: 35201475
[TBL] [Abstract][Full Text] [Related]
10. Enhancing the potency of chemotherapeutic agents by combination with bromelain and N-acetylcysteine - an in vitro study with pancreatic and hepatic cancer cells.
Pillai K; Mekkawy AH; Akhter J; Badar S; Dong L; Liu AI; Morris DL
Am J Transl Res; 2020; 12(11):7404-7419. PubMed ID: 33312377
[TBL] [Abstract][Full Text] [Related]
11. Novel Use of Bromelain and Acetylcysteine (BromAc®) for Pleural Involvement in Pseudomyxoma Peritonei.
Lam AR; Bazzi K; Valle SJ; Morris DL
Case Rep Oncol; 2021; 14(1):628-633. PubMed ID: 33976645
[TBL] [Abstract][Full Text] [Related]
12. Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro: significance of combination therapy.
Amini A; Masoumi-Moghaddam S; Ehteda A; Morris DL
J Exp Clin Cancer Res; 2014 Nov; 33(1):92. PubMed ID: 25425315
[TBL] [Abstract][Full Text] [Related]
13. Depletion of mucin in mucin-producing human gastrointestinal carcinoma: Results from in vitro and in vivo studies with bromelain and N-acetylcysteine.
Amini A; Masoumi-Moghaddam S; Ehteda A; Liauw W; Morris DL
Oncotarget; 2015 Oct; 6(32):33329-44. PubMed ID: 26436698
[TBL] [Abstract][Full Text] [Related]
14. A systematic overview of chemotherapy effects in colorectal cancer.
Ragnhammar P; Hafström L; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937
[TBL] [Abstract][Full Text] [Related]
15. MiR-492 is functionally involved in Oxaliplatin resistance in colon cancer cells LS174T via its regulating the expression of CD147.
Peng L; Zhu H; Wang J; Sui H; Zhang H; Jin C; Li L; Xu T; Miao R
Mol Cell Biochem; 2015 Jul; 405(1-2):73-9. PubMed ID: 25862460
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin for chemotherapeutic treatment and prevention of experimental peritoneal carcinomatosis in rats comparing the intraperitoneal and intravenous application mode.
Hribaschek A; Meyer F; Ridwelski K; Kuester D; Lippert H
Eur Surg Res; 2010; 44(2):74-81. PubMed ID: 20051689
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cell proliferation, cytotoxicity and induction of apoptosis of 1,4-bis(1-naphthyl)-2,3-dinitro-1,3-butadiene in gastrointestinal tumour cell lines and preliminary evaluation of its toxicity in vivo.
Dell'Erba C; Chiavarina B; Fenoglio C; Petrillo G; Cordazzo C; Boncompagni E; Spinelli D; Ognio E; Aiello C; Mariggiò MA; Viale M
Pharmacol Res; 2005 Sep; 52(3):271-82. PubMed ID: 15921920
[TBL] [Abstract][Full Text] [Related]
18. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of chemotherapeutics by bromelain and N-acetylcysteine: sequential and combination therapy of gastrointestinal cancer cells.
Amini A; Masoumi-Moghaddam S; Ehteda A; Liauw W; Morris DL
Am J Cancer Res; 2016; 6(2):350-69. PubMed ID: 27186409
[TBL] [Abstract][Full Text] [Related]
20. Drug-Drug Interactions of Irinotecan, 5-Fluorouracil, Folinic Acid and Oxaliplatin and Its Activity in Colorectal Carcinoma Treatment.
Zoetemelk M; Ramzy GM; Rausch M; Nowak-Sliwinska P
Molecules; 2020 Jun; 25(11):. PubMed ID: 32512790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
